Onconic Therapeutics Inc. (KOSDAQ:476060)
21,250
-200 (-0.93%)
Jun 27, 2025, 3:30 PM KST
Onconic Therapeutics Revenue
Onconic Therapeutics had revenue of 9.17B KRW in the quarter ending March 31, 2025, with 594.91% growth. This brings the company's revenue in the last twelve months to 22.69B, up 80.79% year-over-year. In the year 2024, Onconic Therapeutics had annual revenue of 14.84B, down -29.53%.
Revenue (ttm)
22.69B
Revenue Growth
+80.79%
P/S Ratio
11.57
Revenue / Employee
n/a
Employees
n/a
Market Cap
262.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14.84B | -6.22B | -29.53% |
Dec 31, 2023 | 21.06B | 20.96B | 22,064.25% |
Dec 31, 2022 | 95.00M | 35.00M | 58.33% |
Dec 31, 2021 | 60.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition